source
- Endeavor BioMedicines reports mid-stage trial success for IPF drug, suggests disease reversal potentialEndeavor BioMedicines announced that its experimental therapy for idiopathic pulmonary fibrosis has met its primary goals in a Phase 2 study. The company said the mid‑stage trial showed signs that…
- Zealand and Roche report positive Phase 2 results for amylin drug petrelintide in obesity and diabetesZealand Pharma and Roche announced topline results from a Phase 2 trial of their amylin analogue petrelintide in patients with obesity and type 2 diabetes. The interim data showed that participant…